We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+14.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.62B
AUM Growth
+$77.5M
(+5%)
Cap. Flow
-$61.1M
Cap. Flow
% of AUM
-3.78%
Top 10 Holdings %
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.14M |
| 2 |
Broadcom
AVGO
|
+$3.01M |
| 3 |
Tesla
TSLA
|
+$2.23M |
| 4 |
Twist Bioscience
TWST
|
+$1.76M |
| 5 |
Novavax
NVAX
|
+$1.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$26.2M |
| 2 |
Danaher
DHR
|
+$17.1M |
| 3 |
Amgen
AMGN
|
+$12.4M |
| 4 |
Gilead Sciences
GILD
|
+$9.52M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$7.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.28% |
| 2 | Healthcare | 16.86% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Communication Services | 8.63% |
| 5 | Energy | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Cushman & Wakefield Ltd
CWK
$2.98B
| $117K | 0.01% |
11,093
-1,637
| -13% | -$21.1K |
|
|
CBAY
1052
DELISTED
Cymabay Therapeutics
CBAY
| $115K | 0.01% |
+13,203
| New | +$106K |
|
1053
MiMedx Group
MDXG
$626M
| $114K | 0.01% |
+33,377
| New | +$129K |
|
|
SVC
1054
Service Properties Trust
SVC
$1.1B
| $113K | 0.01% |
2,268
-336
| -13% | -$15.5K |
|
1055
Aclaris Therapeutics
ACRS
$730M
| $112K | 0.01% |
+13,869
| New | +$176K |
|
1056
Coeur Mining
CDE
$15.6B
| $112K | 0.01% |
28,106
+1,501
| +6% | +$5.21K |
|
|
SAND
1057
DELISTED
Sandstorm Gold
SAND
| $112K | 0.01% |
19,270
+2,326
| +14% | +$12.7K |
|
1058
Sabesp
SBS
$19.7B
| $108K | 0.01% |
55,458
-37,354
| -40% | -$73.8K |
|
|
CD
1059
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $104K | 0.01% |
14,931
-1,170
| -7% | -$8.96K |
|
1060
CEMIG Preferred Shares
CIG
$6.09B
| $103K | 0.01% |
59,952
-3,259
| -5% | -$5.2K |
|
1061
Telefônica Brasil
VIV
$22.4B
| $99.9K | 0.01% |
13,193
-717
| -5% | -$5.39K |
|
1062
IAMGOLD
IAG
$8.47B
| $99.6K | 0.01% |
36,759
+3,692
| +11% | +$9.39K |
|
1063
Sabre
SABR
$656M
| $91.4K | 0.01% |
21,300
-2,567
| -11% | -$14.7K |
|
|
HBI
1064
DELISTED
Hanesbrands
HBI
| $90.5K | 0.01% |
17,203
+2,483
| +17% | +$15.6K |
|
1065
Fortuna Silver Mines
FSM
$2.59B
| $89.5K | 0.01% |
23,442
+2,829
| +14% | +$10.1K |
|
1066
JetBlue
JBLU
$1.96B
| $84.6K | 0.01% |
11,625
-3,370
| -22% | -$26.6K |
|
|
SILV
1067
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $84.5K | 0.01% |
11,835
+1,433
| +14% | +$8.77K |
|
1068
Televisa
TV
$1.45B
| $84.2K | 0.01% |
15,924
-866
| -5% | -$4.65K |
|
1069
Payoneer
PAYO
$2.41B
| $83.4K | 0.01% |
13,285
-1,600
| -11% | -$9.52K |
|
|
NTCO
1070
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $69.3K | ﹤0.01% |
13,276
-720
| -5% | -$3.81K |
|
1071
TETRA Technologies
TTI
$1.23B
| $67.6K | ﹤0.01% |
+25,492
| New | +$88.7K |
|
|
FINV
1072
FinVolution Group
FINV
$1.12B
| $65.8K | ﹤0.01% |
+15,782
| New | +$79.8K |
|
1073
Ultrapar
UGP
$6.87B
| $62.3K | ﹤0.01% |
22,811
-1,239
| -5% | -$3.13K |
|
|
NGD
1074
DELISTED
New Gold Inc
NGD
| $60.6K | ﹤0.01% |
55,117
+6,650
| +14% | +$6.78K |
|
|
EXK
1075
Endeavour Silver
EXK
$2.32B
| $59.4K | ﹤0.01% |
15,320
+1,849
| +14% | +$6.13K |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Profund Advisors held 1,192 positions worth $1.62B, up 5% from $1.54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Profund Advisors withdrew a net $61.1M in Q1 2023, closing 103 positions and reducing 580 holdings. Its most notable exit was Cheniere Energy, an estimated $2.09M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Profund Advisors opened a new position in Twist Bioscience worth $1.2M.
- Profund Advisors's largest Q1 2023 buy was Twist Bioscience: 79,459 shares worth $1.2M.
- Profund Advisors added most to NVIDIA in Q1 2023, an estimated $3.14M increase.
- Profund Advisors's biggest Q1 2023 reduction was AbbVie, cutting an estimated $26.2M.
- Profund Advisors fully exited Cheniere Energy in Q1 2023, selling an estimated $2.09M.
- Profund Advisors's ten largest holdings make up 29% of its $1.62B portfolio in Q1 2023.
- Profund Advisors opened 187 new positions and closed 103 in Q1 2023.
- Profund Advisors's portfolio value rose 5% quarter-over-quarter to $1.62B.
Based on Profund Advisors's 13F filing for Q1 2023, filed 12 May 2023.